🇺🇸 FDA
Pipeline program

KK-LC-1 TCR-T cells

192004

Phase 1 mab active

Quick answer

KK-LC-1 TCR-T cells for Gastric Cancer is a Phase 1 program (mab) at IOVANCE BIOTHERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
IOVANCE BIOTHERAPEUTICS, INC.
Indication
Gastric Cancer
Phase
Phase 1
Modality
mab
Status
active

Clinical trials